- Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling2011 | Second Faculty of Medicine
- Midostaurin - the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation2022 | First Faculty of Medicine
- Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)2007 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- 13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking2020 | Second Faculty of Medicine
- Flt3 ligand expands CD4+FoxP3+regulatory T cells in human subjects2013 | Second Faculty of Medicine
- Midostaurin, current overview and clinical experience of IHBT in 2021 - case reports2021 | First Faculty of Medicine
- Flt3 ligand synergizes with granulocyte-colony-stimulating factor in bone marrow mobilization to improve functional outcome after spinal cord injury in the rat2011 | Second Faculty of Medicine, Central Library of Charles University
- Studim viru vakcinie exprimujícího gen pro cytokin Flt3 ligandPublication without faculty affiliation
- Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome2009 | Second Faculty of Medicine
- Study of vaccinia virus recombinant expressing cytokyne Flt3 ligandPublication without faculty affiliation
- Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? : an analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)2007 | First Faculty of Medicine
- Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors2022 | First Faculty of Medicine
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Faculty of Pharmacy in Hradec Králové
- Pilot study of Flt3 Ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas2003 | Faculty of Medicine in Hradec Králové
- Are FLT3 and D835 mutations sufficient indicators for allogeneic transplantation in acute myeloid leukemia?An analysis of patients from the Czech acute leukemia clinical register (alert)Publication without faculty affiliation
- Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα2012 | Central Library of Charles University
- Sunitinib - new clinical studies2007 | Publication without faculty affiliation
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | First Faculty of Medicine
- Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia2012 | First Faculty of Medicine
- Nintedanib, a new angiokinase inhibitor in the treatment of non-small cell lung cancer2013 | Faculty of Medicine in Hradec Králové
- Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study2020 | Faculty of Medicine in Hradec Králové
- Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia2009 | Second Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | First Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | Second Faculty of Medicine
- Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping2023 | First Faculty of Medicine
- Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide2017 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism2021 | Faculty of Pharmacy in Hradec Králové
- Somatické mutace u myelodysplastického syndromu a jejich klinické využití2016 | First Faculty of Medicine
- Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study2023 | Second Faculty of Medicine
- Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria2010 | First Faculty of Medicine